Skip to content
TrialScanner

NCT04313075

A Compassionate Use Study of Leronlimab in Breast Cancer

No phase registeredNo longer availableCYDYLead

Registry record

Lead sponsor
CytoDyn, Inc.
Conditions
Metastatic Triple-Negative Breast Carcinoma
Primary completion
Not registered
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04313075 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04313075: A Compassionate Use Study of... | TrialScanner